ATE350101T1 - Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens - Google Patents
Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagensInfo
- Publication number
- ATE350101T1 ATE350101T1 AT02743320T AT02743320T ATE350101T1 AT E350101 T1 ATE350101 T1 AT E350101T1 AT 02743320 T AT02743320 T AT 02743320T AT 02743320 T AT02743320 T AT 02743320T AT E350101 T1 ATE350101 T1 AT E350101T1
- Authority
- AT
- Austria
- Prior art keywords
- heart failure
- congestive heart
- treatment
- pyridazinone derivative
- mammal
- Prior art date
Links
- 206010007559 Cardiac failure congestive Diseases 0.000 title abstract 2
- 206010019280 Heart failures Diseases 0.000 title abstract 2
- AAILEWXSEQLMNI-UHFFFAOYSA-N 1h-pyridazin-6-one Chemical class OC1=CC=CN=N1 AAILEWXSEQLMNI-UHFFFAOYSA-N 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- GDZXNMWZXLDEKG-UHFFFAOYSA-N n-[4-(4-methyl-6-oxo-4,5-dihydro-1h-pyridazin-3-yl)phenyl]acetamide Chemical compound CC1CC(=O)NN=C1C1=CC=C(NC(C)=O)C=C1 GDZXNMWZXLDEKG-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20011465A FI20011465A0 (fi) | 2001-07-04 | 2001-07-04 | Pyridatsinonijohdannaisen uusi käyttö |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE350101T1 true ATE350101T1 (de) | 2007-01-15 |
Family
ID=8561590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02743320T ATE350101T1 (de) | 2001-07-04 | 2002-07-04 | Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20040180895A1 (de) |
| EP (1) | EP1401450B1 (de) |
| JP (1) | JP2004535457A (de) |
| AT (1) | ATE350101T1 (de) |
| CA (1) | CA2450821A1 (de) |
| DE (1) | DE60217336T2 (de) |
| ES (1) | ES2278930T3 (de) |
| FI (1) | FI20011465A0 (de) |
| WO (1) | WO2003004035A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20040674A0 (fi) | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
| CN107072994B (zh) * | 2014-10-15 | 2020-04-21 | 奥赖恩公司 | 用于治疗运动神经元疾病(例如als)的左西孟旦 |
| WO2021001601A1 (en) | 2019-07-01 | 2021-01-07 | Orion Corporation | Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide |
| US11969424B2 (en) | 2019-12-16 | 2024-04-30 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4397854A (en) * | 1981-05-14 | 1983-08-09 | Warner-Lambert Company | Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents |
| US4517310A (en) * | 1981-07-28 | 1985-05-14 | Berlex Laboratories, Inc. | N-[2-hydroxy-2-(3-hydroxyphenyl)ethyl]-1H-benzimidazole-1-butanamine and use thereof as a cardiotonic agent |
| US4432979A (en) * | 1981-10-26 | 1984-02-21 | William H. Rorer, Inc. | Pyridone compounds |
| JP3131845B2 (ja) * | 1991-06-12 | 2001-02-05 | 帝国臓器製薬株式会社 | 慢性心不全治療剤 |
| FI973804A7 (fi) * | 1997-09-26 | 1999-03-27 | Orion Yhtymae Oy | Levosimendaanin oraalisia koostumuksia |
| FI980901A7 (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
| US5905078A (en) * | 1998-06-19 | 1999-05-18 | Orion Corporation | Use of a pyridazinone derivative |
| FI20011464A0 (fi) * | 2001-07-04 | 2001-07-04 | Orion Corp | Yhdistelmäterapia sydämen vajaatoiminnan hoitoon |
-
2001
- 2001-07-04 FI FI20011465A patent/FI20011465A0/fi unknown
-
2002
- 2002-07-04 CA CA002450821A patent/CA2450821A1/en not_active Abandoned
- 2002-07-04 DE DE60217336T patent/DE60217336T2/de not_active Expired - Lifetime
- 2002-07-04 EP EP02743320A patent/EP1401450B1/de not_active Expired - Lifetime
- 2002-07-04 AT AT02743320T patent/ATE350101T1/de not_active IP Right Cessation
- 2002-07-04 ES ES02743320T patent/ES2278930T3/es not_active Expired - Lifetime
- 2002-07-04 JP JP2003510046A patent/JP2004535457A/ja active Pending
- 2002-07-04 WO PCT/FI2002/000605 patent/WO2003004035A1/en not_active Ceased
-
2004
- 2004-01-05 US US10/750,846 patent/US20040180895A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60217336T2 (de) | 2007-10-04 |
| DE60217336D1 (de) | 2007-02-15 |
| EP1401450A1 (de) | 2004-03-31 |
| FI20011465A0 (fi) | 2001-07-04 |
| ES2278930T3 (es) | 2007-08-16 |
| JP2004535457A (ja) | 2004-11-25 |
| US20040180895A1 (en) | 2004-09-16 |
| WO2003004035A1 (en) | 2003-01-16 |
| EP1401450B1 (de) | 2007-01-03 |
| CA2450821A1 (en) | 2003-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200300906A1 (ru) | Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7 | |
| DE60329316D1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
| DK0771197T3 (da) | Anvendelse af heterocykliske forbindelser som dopamin-D3-ligander | |
| DE60118430D1 (de) | Behandlung gastrointestinaler stroma-tumoren | |
| ATE373474T1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
| NO992282L (no) | Benzonaftyridiner som bronkialterapentika | |
| DE60140871D1 (de) | Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase | |
| NO970164L (no) | Anvendelse av tiazol- og tiadiazolforbindelser som D3 - dopaminreseptorligander | |
| MX2007004041A (es) | Fenilpirazoles. | |
| DE60127537D1 (de) | VERWENDUNG VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLOÄ1,5-bÜPYRIDAZINE ZUR BEHANDLUNG VON NICHTULZERATIVER DYSPEPSIE | |
| ATE429916T1 (de) | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme | |
| DK1401416T5 (da) | Anvendelse af C-kit-inhibitorer til behandling af inflammatorisk tarmsygdom | |
| TNSN06138A1 (fr) | Inhibitors of the mutant form of kit | |
| ATE464895T1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen | |
| DK1735296T3 (da) | Materialer og fremgangsmåder til behandling af koagulationslidelser | |
| ATE350101T1 (de) | Verwendung eines pyridazinon derivates zur behandlung des kongestiven herzversagens | |
| EE200000755A (et) | Püridasinooni derivaadi uus kasutusvõimalus | |
| EA200500242A1 (ru) | Пиперидин-2,5-дионовые памоатные соли и их использование для лечения связанных со стрессом аффективных расстройств | |
| ATE380810T1 (de) | Protein-tyrosine-kinase-inhibitoren | |
| ATE439133T1 (de) | Verwendung von tyrosin-kinase-hemmern zur behandlung von diabetes | |
| ES2187775T3 (es) | Imidazopiridinas. | |
| ATE245986T1 (de) | Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen | |
| DE60120985D1 (de) | Verwendung von fibrate zur herstellung eines arzneimittel zur behandlung von kongestiven herzversagens | |
| ATE326970T1 (de) | Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen | |
| DE60216441D1 (de) | Mittel zur verbesserung der gewebepenetration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |